Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

HAE Haemonetics PE ratio, current and historical analysis

As of Jun 30, 2025, the HAE stock has a PE ratio of 22.41. The calculation is based on the latest EPS of $3.33 and the stock price of $74.61 per share. A decrease of 25% has been observed in the PE ratio compared to its average of 29.7 of the last four quarters.

HAE PE ratio history

How has HAE's PE ratio performed in the past

The mean historical PE ratio of Haemonetics over the last ten years is 104.97. The current 22.41 P/E ratio is 79% lower than the historical average. Looking back at the last ten years, HAE's PE ratio peaked in the Sep 2017 quarter at 641, with a price of $44.87 and an EPS of $0.07. The Mar 2025 quarter marked the lowest point at 18.98, with a price of $63.19 and an EPS of $3.33.

Today
22.89
Average
104.97
Median
66.85
Minimum
18.98
Maximum
641

Haemonetics PE ratio by year

Maximum annual increase: 183.71% in 2015

Maximum annual decrease: -51.48% in 2023

Year PE ratio PE change Price EPS
2025 18.98 -48.41% $63.19 $3.33
2024 36.79 0.93% $85.35 $2.32
2023 36.45 -51.48% $82.75 $2.27
2022 75.12 5.27% $63.85 $0.85
2021 71.36 6.75% $112.04 $1.57
2020 66.85 -18.24% $100.95 $1.51
2019 81.76 -3.89% $87.48 $1.07
2018 85.07 N/A $73.16 $0.86
2017 N/A N/A $40.57 -$0.51
2016 N/A N/A $35.29 -$1.09
2015 133.97 183.71% $44.21 $0.33
2014 47.22 -13.86% $32.11 $0.68
2013 54.82 107.73% $41.66 $0.76
2012 26.39 26.09% $34.84 $1.32
2011 20.93 -14.78% $33.29 $1.59

Haemonetics PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Mar 2025 18.98 -37.36% $63.19 $3.33
Dec 2024 30.3 -7.73% $77.57 $2.56
Sep 2024 32.84 -10.3% $79.8 $2.43
Jun 2024 36.61 -0.49% $82.73 $2.26
Mar 2024 36.79 7.57% $85.35 $2.32
Dec 2023 34.2 -3.42% $85.51 $2.5
Sep 2023 35.41 11.88% $89.58 $2.53
Jul 2023 31.65 -13.17% $85.14 $2.69
Apr 2023 36.45 -12.88% $82.75 $2.27
Dec 2022 41.84 -5.06% $78.65 $1.88
Oct 2022 44.07 -13.59% $74.03 $1.68
Jul 2022 51 -32.11% $67.32 $1.32
Apr 2022 75.12 -39.1% $63.85 $0.85
Jan 2022 123.35 4.51% $53.04 $0.43
Oct 2021 118.03 125.08% $72 $0.61

HAE Price vs fair value

How does HAE's price compare to its estimated fair value based on its growth

HAE average PE ratio chart

What is the average PE ratio of HAE for the past years

The current PE ratio of HAE is lower than its 3, 5 and 10-year averages.

3-year avg
35.85
5-year avg
50.92
10-year avg
104.97
15-year avg
83.33

HAE PE vs peers

What is HAE's PE ratio compared to its peers

In comparison to its peers TMO and SYK, HAE's PE ratio is lower, but it is higher than JNJ's. Haemonetics's PE ratio is trading below the peer average of 30.12.

Stock name PE ratio Market cap
JNJ Johnson & Johnson 17.14 $373.69B
HAE Haemonetics Corp 22.89 $3.66B
MDT Medtronic plc 24.3 $113.02B
TMO Thermo Fisher Scientific Inc 24.63 $158.92B
BDX Becton Dickinson & Co 34.05 $50.56B
SYK Stryker Corp 52.86 $151.5B
CERS Cerus Corp N/A $279.09M
BAX Baxter International Inc N/A $15.92B

Frequently asked questions

What is Haemonetics's PE ratio?

As of Jun 30, 2025, HAE stock has a price to earnings ratio of 22.41.

What is the 3-year average PE ratio for Haemonetics (HAE)?

The 3-year average price to earnings ratio for HAE stock is 35.85.

What is the 5-year average PE ratio for Haemonetics (HAE)?

The 5-year average price to earnings ratio for HAE stock is 50.92.

What is the highest PE ratio for HAE?

Over the last ten years, the quarterly PE ratio reached its highest level at 641 in the Sep 2017 quarter.

How does the current PE ratio for HAE compare to its historical average?

HAE's current price to earnings ratio is 79% below its 10-year historical average.

How is HAE's PE ratio calculated (Haemonetics PE ratio formula)?

To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jun 30, 2025), Haemonetics's share price is $74.61. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $3.33. Therefore, Haemonetics's PE ratio for today is 22.41. PE RATIO(22.41) = STOCK PRICE($74.61) / TTM EPS($3.33)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.